IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, offering promising progress across different clinical and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, much more reliable option for therapeutic use, especially in